03
Oct

Skin treatment developer Dermira came through with a top-of-the-range IPO, banking $125 million to support its pipeline and charting a rare success in the increasingly volatile market for biotech debuts.

…read more

Source: Dermira pulls off a $125M IPO as biotechs wax and wane on Wall Street

    

0 No comments